A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled Trial to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2019
Price : $35 *
At a glance
- Drugs Opiranserin (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Vivozon
- 07 Oct 2019 Status changed from recruiting to completed.
- 20 Jun 2019 Status changed from planning to recruiting.
- 24 Nov 2018 New trial record